Cargando…

Significance and Determinants of Plasma Apelin in Patients With Obstructive Hypertrophic Cardiomyopathy

BACKGROUND: Recent studies suggest apelin has multiple protective effects in some cardiovascular diseases. However, there are few data concerning apelin levels in patients with obstructive hypertrophic cardiomyopathy (OHCM) or the relationship between apelin levels and severity of OHCM. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Chengzhi, Zhang, Changlin, Jia, Ruofei, Qiao, Shubin, Yuan, Jiansong, Jin, Zening
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247182/ https://www.ncbi.nlm.nih.gov/pubmed/35783816 http://dx.doi.org/10.3389/fcvm.2022.904892

Ejemplares similares

Papillary and Trabecular Muscles Have Substantial Impact on Quantification of Left Ventricle in Patients with Hypertrophic Obstructive Cardiomyopathy
por: Yang, Chengzhi, et al.
Publicado: (2022)

Sex differences in atrial remodeling and its relationship with myocardial fibrosis in hypertrophic obstructive cardiomyopathy
por: Bi, Xuanye, et al.
Publicado: (2022)

Preoperative myocardial fibrosis is associated with worse survival after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: A delayed enhanced cardiac magnetic resonance study
por: Chen, Youzhou, et al.
Publicado: (2022)

Gender-related differences in the association between serum uric acid and left ventricular mass index in patients with obstructive hypertrophic cardiomyopathy
por: Zhang, Changlin, et al.
Publicado: (2016)

Sex-related differences in the associations between plasma free fatty acid levels and clinical features in patients with hypertrophic cardiomyopathy
por: Yang, Chengzhi, et al.
Publicado: (2016)

Hypertrophic Obstructive Cardiomyopathy: Comparison of Outcomes After Myectomy or Alcohol Ablation
por: Meng, Xiangbin, et al.
Publicado: (2022)

Stable Rates of Obstructive Hypertrophic Cardiomyopathy in a Contemporary Era
por: Butzner, Michael, et al.
Publicado: (2022)

Quantitative fragmented QRS has a good diagnostic value on myocardial fibrosis in hypertrophic obstructive cardiomyopathy based on clinical-pathological study
por: Bi, Xuanye, et al.
Publicado: (2020)

Thoracoscopic Trans-mitral Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy in the Elderly
por: Wei, Peijian, et al.
Publicado: (2022)

Basic science methods for the characterization of variants of uncertain significance in hypertrophic cardiomyopathy
por: Doh, Chang Yoon, et al.
Publicado: (2023)

Collagen Cross‐Linking Is Associated With Cardiac Remodeling in Hypertrophic Obstructive Cardiomyopathy
por: Bi, Xuanye, et al.
Publicado: (2020)

Global Burden and Improvement Gap of Non-Rheumatic Calcific Aortic Valve Disease: 1990–2019 Findings from Global Burden of Disease Study 2019
por: Yang, Chengzhi, et al.
Publicado: (2022)

Pressure Tracings in Hypertrophic Cardiomyopathy With Dynamic Midventricular Obstruction
por: Jung, Hee-Chan, et al.
Publicado: (2012)

Left ventricular remodeling in hypertrophic cardiomyopathy patients with atrial fibrillation
por: Tian, Hongwei, et al.
Publicado: (2018)

Predictive Values of N-Terminal Pro-B-Type Natriuretic Peptide and Cardiac Troponin I for Myocardial Fibrosis in Hypertrophic Obstructive Cardiomyopathy
por: Zhang, Changlin, et al.
Publicado: (2016)

Selective Interventricular Septal Radiofrequency Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy: Who Can Benefit?
por: Liu, Qiang, et al.
Publicado: (2021)

COVID-19 in Adults With Hypertrophic Cardiomyopathy
por: Arabadjian, Milla E., et al.
Publicado: (2021)

Clinical significance of genetic variation in hypertrophic cardiomyopathy: comparison of computational tools to prioritize missense variants
por: Barbosa, Pedro, et al.
Publicado: (2022)

The Use of Maximum Entropy to Enhance Wave Intensity Analysis: An Application to Coronary Arteries in Hypertrophic Obstructive Cardiomyopathy
por: Francis, Nadine, et al.
Publicado: (2021)

Clinical Efficacy and Safety of Cox-Maze IV Procedure for Atrial Fibrillation in Patients With Hypertrophic Obstructive Cardiomyopathy
por: Meng, Yanhai, et al.
Publicado: (2021)

Midterm Outcome After Septal Myectomy and Medical Therapy in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy
por: Sun, Jiejun, et al.
Publicado: (2022)

Risk Factors of Pulmonary Arterial Hypertension and Its Relationship With Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy
por: Nie, Changrong, et al.
Publicado: (2021)

First-in-man application of Liwen RF™ ablation system in the treatment of drug-resistant hypertrophic obstructive cardiomyopathy
por: Wang, Zihao, et al.
Publicado: (2022)

Hypertrophic Cardiomyopathy: From Phenotype and Pathogenesis to Treatment
por: Cheng, Zeyi, et al.
Publicado: (2021)

Precision and genomic medicine for dilated and hypertrophic cardiomyopathy
por: Nomura, Seitaro, et al.
Publicado: (2023)

Case Report: Integrated echocardiographic assessment guided Liwen procedure for treating obstructive hypertrophic cardiomyopathy with ventricular aneurysm
por: Zhang, Rui, et al.
Publicado: (2023)

Anxiety Predicts Poor Prognosis in Patients With Hypertrophic Cardiomyopathy
por: He, Chao-Jie, et al.
Publicado: (2022)

Transcriptional bursts and heterogeneity among cardiomyocytes in hypertrophic cardiomyopathy
por: Burkart, Valentin, et al.
Publicado: (2022)

Cardiovascular Imaging in Pregnancy: Valvulopathy, Hypertrophic Cardiomyopathy, and Aortopathy
por: Ismail, Haneen, et al.
Publicado: (2022)

Sex differences in clinical outcomes for obstructive hypertrophic cardiomyopathy in the USA: a retrospective observational study of administrative claims data
por: Butzner, Michael, et al.
Publicado: (2022)

Evaluation of Exercise Tolerance in Non-obstructive Hypertrophic Cardiomyopathy With Myocardial Work and Peak Strain Dispersion by Speckle-Tracking Echocardiography
por: Su, Ye, et al.
Publicado: (2022)

Clinical predictors of the presence of obstructive sleep apnea in patients with hypertrophic cardiomyopathy
por: Xu, Haobo, et al.
Publicado: (2021)

Unmasked Obstructive Hypertrophic Cardiomyopathy after Mitral Valve Repair for Severe Mitral Regurgitation
por: Kim, Darae, et al.
Publicado: (2020)

Predictive Value of Plasma Big Endothelin-1 in Adverse Events of Patients With Coronary Artery Restenosis and Diabetes Mellitus: Beyond Traditional and Angiographic Risk Factors
por: Ma, Yue, et al.
Publicado: (2022)

Alcohol Septal Ablation or Septal Myectomy? An Updated Systematic Review and Meta-Analysis of Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy
por: Zheng, Xifeng, et al.
Publicado: (2022)

Non-pharmaceutical Interventions for Hypertrophic Cardiomyopathy: A Mini Review
por: He, Miaomiao, et al.
Publicado: (2021)

Further Considerations in Childhood-Onset Hypertrophic Cardiomyopathy Genetic Testing
por: Monasky, Michelle M., et al.
Publicado: (2021)

Machine Learning for Predicting Heart Failure Progression in Hypertrophic Cardiomyopathy
por: Fahmy, Ahmed S., et al.
Publicado: (2021)

Electrocardiographic and Echocardiographic Predictors of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
por: Mandeş, Leonard, et al.
Publicado: (2022)

Case report: Metastatic melanoma masquerading as apical hypertrophic cardiomyopathy
por: Ashraf, Muddasir, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_904mdtadlr96v4r26hc8h76lmb